The efficacy of the Rességuier method in the treatment of fibromyalgia: a randomised controlled trial
| ISRCTN | ISRCTN62054712 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN62054712 |
| Protocol serial number | N/A |
| Sponsor | University of Florence (Italy) |
| Funder | University of Florence (Italy) - Department of Medicine |
- Submission date
- 15/12/2008
- Registration date
- 23/12/2008
- Last edited
- 23/12/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Susanna Maddali Bongi
Scientific
Scientific
Associazione per lo studio della Sclerosi Sistemica e delle Malattie Fibrosanti (ASSMaF)
Viale Pieraccini 18
Firenze
50139
Italy
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled single centre trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | Rehabilitation of fibromyalgia: efficacy of the Rességuier method - a randomised controlled trial |
| Study objectives | Rehabilitation holds an important role in the treatment of fibromyalgia syndrome (FMS). Despite numerous studies, an agreement on a specific rehabilitation line, adaptable to the needs of a heterogeneous group of patients, has not been found yet. The Rességuier method is a rehabilitation technique never experimented in fibromyalgia. |
| Ethics approval(s) | Not provided at the time of registration |
| Health condition(s) or problem(s) studied | Fibromyalgia |
| Intervention | FMS patients were recruited and randomly assigned to the Group A and Group B. The patients of Group A were individually treated with the Rességuier method for 8 weeks, 1 session a week. The patients of Group B were observed for 8 weeks. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Reduction of pain (Numerical Rating Scale [NRS]: 0 - 10) |
| Key secondary outcome measure(s) |
1. Quality of movement (NRS: 0 - 10) |
| Completion date | 10/12/2007 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Other |
| Sex | All |
| Target sample size at registration | 36 |
| Key inclusion criteria | 1. Diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) criteria 2. No age limits |
| Key exclusion criteria | Does not meet the inclusion criteria |
| Date of first enrolment | 10/01/2007 |
| Date of final enrolment | 10/12/2007 |
Locations
Countries of recruitment
- Italy
Study participating centre
Associazione per lo studio della Sclerosi Sistemica e delle Malattie Fibrosanti (ASSMaF)
Firenze
50139
Italy
50139
Italy
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
